Related Experiment Video
Updated: May 16, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
CK2 enzyme affinity against c-myc 424-434 substrate in human lung cancer tissue
Ilhan Yaylim1, Nazli Ezgi Ozkan, Turgut Isitmangil
1Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. ilhanyaylim@gmail.com
Abstract:
CK2 is a serine threonine kinase that participates in a variety of cellular processes with more than 300 defined substrates. This critical enzyme is known to be upregulated in cancers, but the role of this upregulation in carcinogenesis is not yet fully understood but c-myc, one of the defined CK2 substrates, is a well-known proto- oncogene that is normally essential in developmental process but is also involved in tumor development. We evaluated the optimal enzyme and substrate concentrations for CK2 activity in both neoplastic and non-neoplastic human lung tissues using the c-myc 424-434 peptide (EQKLISEEDL) as a substrate. The activities measured for the neoplastic tissue were 600-750 U/mg protein while those for the control tissue was in the range of 650-800 U/ mg. Km value for c-myc peptide was determined as 0.33 μM in non-neoplastic tissue and 0.18 μM in neoplastic tissue. In this study, we did not observe an increased activity in the neoplastic tissue when compared with the non-neoplastic lung tissue, but we recorded two times higher affinity for c-myc 424-434 in cancer tissue. Considering the metabolic position of c-myc 424-434, our results suggest that phosphorylation by CK2 may be important in dimerization and thus it might affect the regulation of c-myc in cancer tissues.
Insights
Protein kinase CK2 activity was studied in lung cancer. While overall activity was similar, CK2 showed higher affinity for the c-myc substrate in neoplastic tissues, suggesting a role in cancer development.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein kinase CK2 (casein kinase 2) is a serine/threonine kinase involved in numerous cellular processes.
- CK2 is known to be upregulated in various cancers, but its precise role in carcinogenesis remains unclear.
- The proto-oncogene c-myc, a substrate of CK2, plays a role in both normal development and tumor progression.
Purpose of the Study:
- To evaluate optimal enzyme and substrate concentrations for CK2 activity in human lung tissues.
- To compare CK2 activity and substrate affinity in neoplastic versus non-neoplastic lung tissues using a c-myc peptide substrate.
- To investigate the potential role of CK2-mediated phosphorylation of c-myc in lung cancer.
Main Methods:
- Enzyme kinetics assays were performed on neoplastic and non-neoplastic human lung tissues.
- The c-myc 424-434 peptide (EQKLISEEDL) was used as a substrate to measure CK2 activity.
- Kinetic parameters, including Km values, were determined for CK2 in both tissue types.
Main Results:
- CK2 activity levels (U/mg protein) were comparable between neoplastic (600-750 U/mg) and non-neoplastic (650-800 U/mg) lung tissues.
- The Michaelis constant (Km) for the c-myc peptide substrate was significantly lower in neoplastic tissue (0.18 μM) compared to non-neoplastic tissue (0.33 μM), indicating higher substrate affinity.
- A two-fold higher affinity of CK2 for the c-myc 424-434 peptide was observed in cancer tissue.
Conclusions:
- Despite similar overall CK2 activity, neoplastic lung tissue exhibits a significantly higher affinity for the c-myc substrate.
- This increased affinity suggests that CK2-mediated phosphorylation of c-myc may be crucial for its dimerization and regulation in lung cancer.
- These findings highlight a potential mechanism by which CK2 contributes to tumor development through altered c-myc regulation.
Related Concept Videos
Inhibition of Cdk Activity
Induced Pluripotent Stem Cells
Somatic cells are...
Cell Specific Gene Expression
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
